BMO Capital raised the firm’s price target on Oracle to $96 from $95 but keeps a Market Perform rating on the shares. The company’s Q3 results were "solid if unspectacular", with license revenue a bit below estimate though not as important as its cloud business where the management is guiding for growth for the quarter and the year to improve to 30% in constant currency, the analyst tells investors in a research note. BMO adds that Oracle’s integration of Cerner appears to be going well, though the stock’s valuation is keeping the firm on the sidelines.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ORCL: